TY - JOUR
T1 - Outcome Predictors of Hardware Complications in Head and Neck Free Flap Reconstruction
AU - Talwar, Abhinav
AU - Asthana, Shravan
AU - Silva-Nash, Jennifer
AU - Gharzai, Laila A.
AU - Samant, Sandeep
AU - Patel, Urjeet
AU - Stepan, Katelyn
N1 - Publisher Copyright:
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2025
Y1 - 2025
N2 - Objectives: Osteocutaneous free flap reconstruction can be complicated by hardware failure. The present study investigates the frequency and predictors of hardware failure in head and neck osteocutaneous reconstruction. Methods: Patients who underwent osteocutaneous head and neck free flap reconstruction between the years of 2014 and 2022 were identified at our institution. Hardware failure was defined as hardware infection, screw plate loosening, exposed hardware, migration, deformation, or fracture. Results: We identified 47 patients who met the inclusion criteria for this study. Common indications for intervention included squamous cell carcinoma (35, 74%) and osteoradionecrosis (8, 17%). Most operations used fibular flaps (31, 66%) or osteocutaneous radial forearm flaps (12, 26%). The median age at the time of reconstruction was 66 years (IQR: 59 to 72). In total, 17 (36%) patients experienced hardware failure in the postoperative period. On univariable analysis, estimated blood loss (P=0.01) and early postoperative infectious complication (P=0.03) were the only significant predictors of hardware failure. On multivariable analysis, these factors retained significance. Estimated blood loss had an OR of 1.004 (95% CI: 1.001-1.008; P=0.01), and infectious complication had an OR of 5.22 (95% CI: 1.28-24.84; P=0.03). Conclusion: The incidence of hardware failure among patients who undergo head and neck osteocutaenous free flap reconstruction is high (36%). Patients with infectious complications and high estimated blood loss may be more likely to develop hardware failure.
AB - Objectives: Osteocutaneous free flap reconstruction can be complicated by hardware failure. The present study investigates the frequency and predictors of hardware failure in head and neck osteocutaneous reconstruction. Methods: Patients who underwent osteocutaneous head and neck free flap reconstruction between the years of 2014 and 2022 were identified at our institution. Hardware failure was defined as hardware infection, screw plate loosening, exposed hardware, migration, deformation, or fracture. Results: We identified 47 patients who met the inclusion criteria for this study. Common indications for intervention included squamous cell carcinoma (35, 74%) and osteoradionecrosis (8, 17%). Most operations used fibular flaps (31, 66%) or osteocutaneous radial forearm flaps (12, 26%). The median age at the time of reconstruction was 66 years (IQR: 59 to 72). In total, 17 (36%) patients experienced hardware failure in the postoperative period. On univariable analysis, estimated blood loss (P=0.01) and early postoperative infectious complication (P=0.03) were the only significant predictors of hardware failure. On multivariable analysis, these factors retained significance. Estimated blood loss had an OR of 1.004 (95% CI: 1.001-1.008; P=0.01), and infectious complication had an OR of 5.22 (95% CI: 1.28-24.84; P=0.03). Conclusion: The incidence of hardware failure among patients who undergo head and neck osteocutaenous free flap reconstruction is high (36%). Patients with infectious complications and high estimated blood loss may be more likely to develop hardware failure.
KW - flap failure
KW - hardware
KW - hardware failure
KW - osteocutaneous free flap
UR - http://www.scopus.com/inward/record.url?scp=85218770195&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85218770195&partnerID=8YFLogxK
U2 - 10.1097/COC.0000000000001180
DO - 10.1097/COC.0000000000001180
M3 - Article
C2 - 39967011
AN - SCOPUS:85218770195
SN - 0277-3732
JO - American Journal of Clinical Oncology: Cancer Clinical Trials
JF - American Journal of Clinical Oncology: Cancer Clinical Trials
M1 - 10.1097/COC.0000000000001180
ER -